🇺🇸 FDA
Pipeline program

IDE574

IDE574-001

Phase 2 small_molecule active

Quick answer

IDE574 for ER+, HER 2- Breast Cancer is a Phase 2 program (small_molecule) at IDEAYA Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
IDEAYA Biosciences
Indication
ER+, HER 2- Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials